[1] 何明艳, 朱碧琪, 钟媛, 等. 2005-2013年中国女性乳腺癌发病及死亡趋势分析[J]. 中华疾病控制杂志, 2019, 23(1): 10.
[2] 沈松杰, 孙强. 中国女性乳腺癌筛查现状及适宜模式探索[J]. 协和医学杂志, 2018, 9(4): 298. doi: 10.3969/j.issn.1674-9081.2018.04.003
[3] 师金, 梁迪, 李道娟, 等. 全球女性乳腺癌流行情况研究[J]. 中国肿瘤, 2017, 26(9): 683.
[4] 左婷婷, 陈万青. 中国乳腺癌全人群生存率分析研究进展[J]. 中国肿瘤临床, 2016, 43(14): 639. doi: 10.3969/j.issn.1000-8179.2016.14.503
[5] 王泽, 王建东, 陈晓燕, 等. 早期乳腺癌保乳手术和改良根治术的临床疗效比较[J]. 解放军医学院学报, 2018, 39(11): 955. doi: 10.3969/j.issn.2095-5227.2018.11.007
[6] 彭德峰, 赵云霞, 朱正志, 等. Kodama法淋巴结清扫在乳腺癌Auchincloss术中的应用[J]. 蚌埠医学院学报, 2015, 40(11): 1482.
[7] 王懋莉, 吴克瑾. 早期乳腺癌腋窝处理研究热点[J]. 中国实用外科杂志, 2018, 38(11): 1260.
[8] KILLELEA BK, LONG JB, DANG W, et al. Associations between sentinel lymph node biopsy and complications for patients with ductal carcinoma in situ[J]. Ann Surg Oncol, 2018, 25(6): 1521. doi: 10.1245/s10434-018-6410-0
[9] 阳宁静, 任静, 李吉满. 乳腺癌Ⅰ、Ⅱ组淋巴结Ki67定性、定量表达差异及相关分析[J]. 蚌埠医学院学报, 2018, 43(9): 1125.
[10] VANDORPE T, SMEETS A, VAN CALSTER B, et al. Lobular and nonlobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4292 consecutive patients[J]. Breast Cancer Res Treat, 2011, 128(2): 429. doi: 10.1007/s10549-011-1565-4
[11] 沈晓东, 潘高峰, 刘维燕, 等. 乳腺癌临床病理特征对预后判断的价值[J]. 蚌埠医学院学报, 2016, 41(12): 1642.
[12] 惠锐. 乳腺癌腋窝淋巴结转移规律的回顾性分析[J]. 肿瘤防治杂志, 2004, 11(9): 933. doi: 10.3969/j.issn.1673-5269.2004.09.012
[13] CETINTA SK, KURT M, OZKAN L, et al. Factors influencing axillary node metastasis in breast cancer[J]. Tumori, 2006, 92(5): 416. doi: 10.1177/030089160609200509
[14] GERMAIN D.Estrogen carcinogenesis in breast cancer[J]. Endocrinol Metab Clin North Am, 2011, 40(3): 473. doi: 10.1016/j.ecl.2011.05.009
[15] YIP CH, TAIB NA, TAN GH, et al. Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery?[J]. World J Surg, 2009, 33(1): 54. doi: 10.1007/s00268-008-9782-7
[16] CHADHA M, CHABON AB, FRIEDMANN P, et al. Predictors of axillary lymph node metastases in patients with T1 breast canner. A multivariate anlysis[J]. Cancer, 2015, 73(2): 350.
[17] 姜朋丽, 付彤, 武盼盼, 等. 不同T分期乳腺癌患者分子分型与腋窝淋巴结转移的关系及其临床意义[J]. 吉林大学学报(医学版), 2016, 42(1): 144.
[18] 李玉龙, 彭德峰, 王自豪, 等. 三阴性乳腺癌210例临床分析[J]. 蚌埠医学院学报, 2019, 44(9): 1173.
[19] BARONE RE, TUCHER JB, PEREZ JM, et al. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer[J]. Am Surg, 2005, 71(1): 66. doi: 10.1177/000313480507100113
[20] 汪成, 季福, 徐明, 等. 乳腺浸润性微乳头状癌的病理特征及其与转移的关系[J]. 上海交通大学学报(医学版), 2011, 31: 72. doi: 10.3969/j.issn.1674-8115.2011.01.017
[21] 张继博, 贾勇圣, 佟仲生, 等. 晚期乳腺浸润性小叶癌与浸润性导管癌临床病理特征及预后比较[J]. 肿瘤, 2017, 37(11): 1188. doi: 10.3781/j.issn.1000-7431.2017.33.579
[22] CAO AY, HUANG L, WU J, et al. Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population[J]. World J Surg Oncol, 2012, 10: 152. doi: 10.1186/1477-7819-10-152
[23] GOLDHIRSCH A, WOOD WC, GOATES AS, et al. Strategies for subtypes dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the primary therapy of early breast cancer 2011[J]. Ann Onco1, 2011, 22(8): 1736. doi: 10.1093/annonc/mdr304
[24] LI L, CHEN LZ.Factors influencing axillary lymph node metastasis in invasive breast cancer[J]. Asian Pac J Cancer Prev, 2012, 13(1): 251. doi: 10.7314/APJCP.2012.13.1.251
[25] LOPEZ JK, BASSETT LW.Invasive lobular carcinoma of the breast: spectrum of mammographic, US. and MR imaging findings[J]. Radiographics, 2009, 29(1): 165. doi: 10.1148/rg.291085100
[26] PESTALOZZI BC, ZAHRIEH D, MALLON E, et al. Distinct clinical and prognostic features ofinfiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials[J]. J Clin Oncol, 2008, 26(18): 3006 doi: 10.1200/JCO.2007.14.9336
[27] ELSTON CW, ELLIS IO.The value of histological grade in breast cancer: experience from a large study with long term follow up[J]. Histopathology, 2002, 41(3A): 154. doi: 10.1046/j.1365-2559.2002.14892.x
[28] CHEN X, HE Y, WANG J, et al. Feasibility of using negative ultrasonography results of axillary lymph nodes to predict sentinel lymph node metastasis in breast cancer patients[J]. Cancer Med, 2018. DOI:10.1002/cam4.1606.
[29] WOO CS, SILBERMAN H, NAKAMURA SK, et al. Lymph node status combined with lymphovaseular invasion creates a more powerful tool for predicting outcome in patients with in vasive breast cancer[J]. Arn J Surg, 2002, 184(4): 337. doi: 10.1016/S0002-9610(02)00950-9
[30] CORNWELL LB, MCMASTERS KM, CHAGPAR AB.The impact of lymphovascular invasion on lymph node status in patients with breast cancer[J]. Am Surg, 2011, 77(7): 874. doi: 10.1177/000313481107700722
[31] TSENG HS, CHEN LS, KUO SJ, et al. Tumor characteristics of breast cancer in predicting axillary lymph node metastasis[J]. Med Sci Monit, 2014, 20: 1155. doi: 10.12659/MSM.890491
[32] 张燕, 孙晓, 赵桐, 等. 术中快速预测乳腺癌非前哨淋巴结转移模型的建立与验证研究[J]. 中国癌症杂志, 2017, 27(5): 368.
[33] ZHANG L, HUANG Y, YANG C, et al. Application of a carbon nanoparticle suspension for sentinel lymph nodemapping in patients with early breast cancer: a retrospective cohort study[J]. World J Surg Oncol, 2018, 16(1): 112. doi: 10.1186/s12957-018-1414-6
[34] NATHANSON SD, KWON D, KAPKE A, etal. The role of lymph node metastasis in the systemic dissemination ofbreast cancer. [J]. Ann Surg Onco1, 2009, 16(12): 3396. doi: 10.1245/s10434-009-0659-2